Literature DB >> 19806257

Proteomic and functional characterisation of platelet microparticle size classes.

William L Dean1, Menq J Lee, Timothy D Cummins, David J Schultz, David W Powell.   

Abstract

UNLABELLED: Activated platelets release large lipid-protein complexes termed microparticles. These platelet microparticles (PMP) are composed of vesicular fragments of the plasma membrane and alpha-granules. PMP facilitate coagulation, promote platelet and leukocyte adhesion to the subendothelial matrix, support angiogenesis and stimulate vascular smooth muscle proliferation.
OBJECTIVES: PMP were separated into 4 size classes to facilitate identification of active protein and lipid components. PMP were obtained from activated human platelets and separated into 4 size classes by gel filtration chromatography. Proteins were identified using 2-dimensional, liquid chromatography tandem mass spectrometry. Functional effects on platelets were determined using the PFA-100 and on endothelial cells by measuring transendothelial cell electrical resistance. PMP size classes differed significantly in their contents of plasma membrane receptors and adhesion molecules, chemokines, growth factors and protease inhibitors. The two smallest size classes (3 and 4) inhibited collagen/adenosine-diphosphate-mediated platelet thrombus formation, while fractions 2 and 4 stimulated barrier formation by endothelial cells. Heat denaturation blocked the effect of fraction 4 on endothelial cell function, but not fraction 2 implying that the active component in fraction 4 is a protein and in fraction 2 is a heat-stable protein or lipid but not sphingosine-1-phosphate. Proteomic and functional analysis of PMP size fractions has shown that PMP can be separated into different size classes that differ in protein components, protein/lipid ratio, and functional effects on platelets and endothelial cells. This analysis will facilitate identification of active components in the PMP and clarify their involvement in diseases such as atherosclerosis and cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19806257      PMCID: PMC2861410          DOI: 10.1160/TH09-04-243

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  44 in total

1.  Platelet microparticles induce angiogenesis in vitro.

Authors:  Hyun Kyung Kim; Kyung Soon Song; Jun-Ho Chung; Kyoung Rhan Lee; Se-Na Lee
Journal:  Br J Haematol       Date:  2004-02       Impact factor: 6.998

2.  Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles.

Authors:  Robert Flaumenhaft; James R Dilks; Jennifer Richardson; Eva Alden; Sunita R Patel-Hett; Elisabeth Battinelli; Giannoula L Klement; Martha Sola-Visner; Joseph E Italiano
Journal:  Blood       Date:  2008-09-18       Impact factor: 22.113

3.  Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules.

Authors:  H F Heijnen; A E Schiel; R Fijnheer; H J Geuze; J J Sixma
Journal:  Blood       Date:  1999-12-01       Impact factor: 22.113

4.  Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism.

Authors:  René J Berckmans; Rienk Nieuwland; Paul Peter Tak; Anita N Böing; Fred P H T M Romijn; Maarten C Kraan; Ferdinand C Breedveld; C Erik Hack; Augueste Sturk
Journal:  Arthritis Rheum       Date:  2002-11

5.  A high-performance liquid chromatographic method to measure sphingosine 1-phosphate and related compounds from sphingosine kinase assays and other biological samples.

Authors:  T B Caligan; K Peters; J Ou; E Wang; J Saba; A H Merrill
Journal:  Anal Biochem       Date:  2000-05-15       Impact factor: 3.365

6.  Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood.

Authors:  Takamitsu Sano; Daniel Baker; Tamas Virag; Atsushi Wada; Yutaka Yatomi; Tetsuyuki Kobayashi; Yasuyuki Igarashi; Gabor Tigyi
Journal:  J Biol Chem       Date:  2002-04-02       Impact factor: 5.157

7.  Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells.

Authors:  Y Yatomi; T Ohmori; G Rile; F Kazama; H Okamoto; T Sano; K Satoh; S Kume; G Tigyi; Y Igarashi; Y Ozaki
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

8.  Effects of severe hypertension on endothelial and platelet microparticles.

Authors:  Richard A Preston; Wenche Jy; Joaquin J Jimenez; Lucia M Mauro; Lawrence L Horstman; Madelyn Valle; Gerard Aime; Yeon S Ahn
Journal:  Hypertension       Date:  2003-02       Impact factor: 10.190

9.  Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery.

Authors:  Sandra L Pfister
Journal:  Hypertension       Date:  2004-01-12       Impact factor: 10.190

Review 10.  Exosome: from internal vesicle of the multivesicular body to intercellular signaling device.

Authors:  K Denzer; M J Kleijmeer; H F Heijnen; W Stoorvogel; H J Geuze
Journal:  J Cell Sci       Date:  2000-10       Impact factor: 5.285

View more
  47 in total

Review 1.  Clinical relevance of microparticles from platelets and megakaryocytes.

Authors:  Joseph E Italiano; Albert T A Mairuhu; Robert Flaumenhaft
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

Review 2.  Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery.

Authors:  Michael L Merchant; Ilse M Rood; Jeroen K J Deegens; Jon B Klein
Journal:  Nat Rev Nephrol       Date:  2017-10-30       Impact factor: 28.314

3.  Abnormal P-selectin localization during megakaryocyte development determines thrombosis in the gata1low model of myelofibrosis.

Authors:  Eva Zetterberg; Maria Verrucci; Fabrizio Martelli; Maria Zingariello; Laura Sancillo; Emanuela D'Amore; Rosa Alba Rana; Anna Rita Migliaccio
Journal:  Platelets       Date:  2013-10-31       Impact factor: 3.862

Review 4.  Microparticles and cardiovascular diseases.

Authors:  Christos Voukalis; Eduard Shantsila; Gregory Y H Lip
Journal:  Ann Med       Date:  2019-06-17       Impact factor: 4.709

Review 5.  Extracellular vesicles in coronary artery disease.

Authors:  Chantal M Boulanger; Xavier Loyer; Pierre-Emmanuel Rautou; Nicolas Amabile
Journal:  Nat Rev Cardiol       Date:  2017-02-02       Impact factor: 32.419

6.  Aging- and activation-induced platelet microparticles suppress apoptosis in monocytic cells and differentially signal to proinflammatory mediator release.

Authors:  Elena M Vasina; Sandra Cauwenberghs; Mareike Staudt; Marion Ah Feijge; Christian Weber; Rory R Koenen; Johan Wm Heemskerk
Journal:  Am J Blood Res       Date:  2013-05-05

Review 7.  Circulating membrane-derived microvesicles in redox biology.

Authors:  Michael Craig Larson; Cheryl A Hillery; Neil Hogg
Journal:  Free Radic Biol Med       Date:  2014-04-18       Impact factor: 7.376

8.  Dissecting the biochemical architecture and morphological release pathways of the human platelet extracellular vesiculome.

Authors:  Silvia H De Paoli; Tseday Z Tegegn; Oumsalama K Elhelu; Michael B Strader; Mehulkumar Patel; Lukas L Diduch; Ivan D Tarandovskiy; Yong Wu; Jiwen Zheng; Mikhail V Ovanesov; Abdu Alayash; Jan Simak
Journal:  Cell Mol Life Sci       Date:  2018-02-09       Impact factor: 9.261

Review 9.  Extracellular vesicle isolation and characterization: toward clinical application.

Authors:  Rong Xu; David W Greening; Hong-Jian Zhu; Nobuhiro Takahashi; Richard J Simpson
Journal:  J Clin Invest       Date:  2016-04-01       Impact factor: 14.808

10.  A novel method for overexpression of peroxisome proliferator-activated receptor-γ in megakaryocyte and platelet microparticles achieves transcellular signaling.

Authors:  J Sahler; C Woeller; S Spinelli; N Blumberg; R Phipps
Journal:  J Thromb Haemost       Date:  2012-12       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.